Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer
Clinical trial NCT00216073 · TERMINATED
Trial details
- NCT number
- NCT00216073
- Sponsor
- Hoosier Cancer Research Network
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2006-10-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.